. Author manuscript; available in PMC: 2008 Dec 1.

Published in final edited form as: J Allergy Clin Immunol. 2008 Nov;122(5):914–920. doi: 10.1016/j.jaci.2008.08.034

TABLE II.

Anti—cockroach and anti—mouse IgE and symptoms (n = 404)

	Anti—cockroach IgE (≥0.35 IU/mL)	Anti—mouse IgE (≥0.35 IU/mL)	Both anti—cockroach and anti—mouse IgE (≥0.35 IU/mL)
Early wheeze
Bivariate OR (95% CI)	3.31 (1.77–6.21)^†	4.58 (2.34–8.98)^†	9.66 (3.42–27.30)^†
Multivariate OR (95% CI)	3.25 (1.69–6.24)	4.18 (2.07–8.42)^†	8.11 (2.77–23.74)^†
Rhinitis
Bivariate OR (95% CI)	1.83 (0.93–3.60)	2.18 (1.03–4.58)^*	6.50 (1.49–28.40)^*
Multivariate OR (95% CI)	1.93 (0.97–3.84)	2.18 (1.02–4.65)^*	6.64 (1.50–29.45)^*
Atopic dermatitis
Bivariate OR (95% CI)	3.04 (1.62–5.70)^†	2.52 (1.30–4.87)^*	4.72 (1.77–12.56)^†
Multivariate OR (95% CI)	2.90 (1.49–5.65)^†	2.13 (1.05–4.31)^*	3.72 (1.31–10.54)^*

Multivariate models were adjusted for maternal asthma, sex, ethnicity, and prenatal and postnatal environmental tobacco smoke exposure.

P < .05.

^†

P < .005.